Contact Information
Department of Clinical Sciences
Hospital Universitari de Bellvitge. Facultat de Medicina de la Universitat de Barcelona. Campus Bellvitge.Feixa Llarga s/n. 932607412 smartinezy(a)ub.edu
Teaching imparted (current)
Malalties del Sistema Nerviós -
Medicina -
Universidad de Barcelona.
Academic training
Medicina i Cirurgia
. Dep.Medicina. Universitat de Barcelona
. 10/06/2002
. (Ph.D.)Programa de Direcció de Serveis Integrals de Salut
. ESADE Bussiness School
. 2004
. (Official Master)Metodología de la Investigación. Diseño y estadística en ciencias de la salud
. Universitat Autònoma de Barcelona
. 2013
. (Official Master)Especialista en Neurologia
. Hospital Unversitari de Bellvitge
. 1994
. (Specialized Training)Medicina i Cirurgia
. Universitat de Barcelona
. 20/10/1990
. (Diploma / Degree / Activities)
Professional experience
Professor Associat.
Facultat de Medicina. Campus Bellvitge. Universitat de Barcelona.
2009Metge Adjunt. Neurologia.
Mútua General de Terrassa.
1996 - 1997Metge Adjunt. Neurologia. Interí.
Hospital de Viladecans. ICS.
1997 - 2001Metge Adjunt. Neurologia. Interí.
Hospital de Bellvitge. ICS.
2001 - 2006Metge Adjunt. Servei de Neurología. Estatutari.
Hospital de Bellvitge. ICS.
2006
Research interests
Neurociencias clínicas y experientales
Journal Publications
José Meca-Lallana; Juan Antonio García-Merino; Sergio Martínez-Y élamos; Angela Vidal-Jordana; Lucienne Costa; Sara Eichau; Àlex Rovira; Luis Brieva; Eduardo Agüera; Alfredo Rodríguez-Antigüedad Zarranz(2021).
Identificaction of patients with relapsing multiple sclerosis elegible for high efficacy therapies.Neurodegenerative Disease Management. ISSN: 1758-2024Jesús Ribas; Joana Valcárcel; Esther Alba; Yolanda Ruíz; Daniel Cuartero; Adriana Iriarte; José María Mora-Luján; Marta Huguet; Pau Cerdà; Sergio Martínez-Yélamos; Xavier Corbella; Salud Santos; Antoni Riera-Mestre(2021).
Catheter-Directed Therapies in Patients with Pulmonary Embolism: Predictive Factors of In-Hospital Mortality and Long-Term Follow-Up.Journal of Clinical Medicine, 10(20), p. 4716
. Institutional Repository. ISSN: 2077-0383Comabella, Manuel; Sastre-Garriga, Jaume; Borras, Eva; Villar, Luisa M; Saiz, Albert; Martinez-Yelamos, Sergio; Garcia-Merino, Juan Antonio; Pinteac, Rucsanda; Fissolo, Nicolas; Sanchez Lopez, Antonio J; Costa-Frossard, Lucienne; Blanco, Yolanda; Llufriu, Sara; Vidal-Jordana, Angela; Sabido, Eduard; Montalban, Xavier(2021).
CSF Chitinase 3-Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis.Neurology. Neuroimmunology & Neuroinflammation, 8(6), p. e1082. ISSN: 2332-7812V. Casado; I.Buenaventura; L. Brieva; S. Martínez-Yélamos; G. Martín; S. Presas Rodríguez; M. Hervas; J.J. Hernández; E. Munteis; A. Escartín; L. Gubieras; M.A. Mañé-Martínez; L. Ramió-Torrrentà(2021).
Direct costs of relapses in patients with relapsing-remitting multiple sclerosis.Neurology Prespectives, 27(4), pp. 160 - 169. ISSN: 2667-0496Maristany Bosch, M.; Cuervo, G,; Matas Martín, E.; Veciana de las Heras, M.; Pedro Pérez, J.; Martínez Yélamos, S.; Sabé Fernández, N.(2021).
Neurological toxicity due to antimonial treatment for refractory visceral leishmaniasis.Clinical Neurophysiology Practice, 6, pp. 164 - 167
. https://doi.org/10.1016/j.cnp.2021.03.008. ISSN: 2467-981XMatas, E. ; Bau, L. ; Romero-Pinel, L. ; Leon, I. ; Martinez-Yelamos, A. ; Martinez-Yelamos, S.(2020).
Benign multiple sclerosis: is the edss scale enough to define it?.Multiple Sclerosis Journal, 26(Suppl 3), pp. 518 - 518. ISSN: 1352-4585Romero-Pinel, L ; Bau, L.; Matas, E ; Leon, I ; Juvany, R ; Jodar, R ; Martinez-Yelamos, A ; Martinez-Yelamos, S(2020).
Cost of a relapse-free patient in relapsing-remitting multiple sclerosis, a reliable result-based health indicator.Multiple Sclerosis Journal, 26(Suppl 3), pp. 143 - 144. ISSN: 1352-4585Bau, L ; Matas, E ; Romero-Pinel, L ; Leon, I ; Martinez-Yelamos, S ; Martinez-Yelamos, A(2020).
Assessment of multiple sclerosis severity score and age-related multiple sclerosis severity score as health indicators in a population-based cohort.Multiple Sclerosis Journal, 26(Suppl 3), pp. 132 - 132. ISSN: 1352-4585